The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series
H Zeng, D Wang, J Nie, H Liang, J Gu, A Zhao… - Signal transduction and …, 2020 - nature.com
Convalescent plasma (CP) transfusion has been indicated as a promising therapy in the
treatment for other emerging viral infections. However, the quality control of CP and …
treatment for other emerging viral infections. However, the quality control of CP and …
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
K Duan, B Liu, C Li, H Zhang, T Yu… - Proceedings of the …, 2020 - National Acad Sciences
Currently, there are no approved specific antiviral agents for novel coronavirus disease
2019 (COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test …
2019 (COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test …
[HTML][HTML] COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: a multicenter interventional study
S Alsharidah, M Ayed, RM Ameen, F Alhuraish… - International Journal of …, 2021 - Elsevier
Objective To study the effectiveness of COVID-19 convalescent plasma (CCP) therapy for
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study
Background Convalescent plasma (CP) has been widely used to treat COVID-19 and is
under study. However, the variability in the current clinical trials has averted its wide use in …
under study. However, the variability in the current clinical trials has averted its wide use in …
Efficacy and safety of convalescent plasma therapy in patients with COVID-19: arapid review of case series
DD Putera, MS Hardianti - … of the Medical Sciences (Berkala Ilmu …, 2020 - journal.ugm.ac.id
Abstract Coronavirus disease 2019 (COVID-19) has become a world pandemic since early
2020. Currently, there is no established treatment to combat this potentially fatal disease …
2020. Currently, there is no established treatment to combat this potentially fatal disease …
Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates
While there is no proven treatment available for coronavirus disease 2019 (COVID-19),
convalescent plasma (CP) may provide therapeutic relief as the number of cases escalate …
convalescent plasma (CP) may provide therapeutic relief as the number of cases escalate …
The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study
K Duan, B Liu, C Li, H Zhang, T Yu, J Qu, M Zhou… - MedRxiv, 2020 - medrxiv.org
Currently, there are no approved specific antiviral agents for 2019 novel coronavirus
disease (COVID-19). In this study, ten severe patients confirmed by real-time viral RNA test …
disease (COVID-19). In this study, ten severe patients confirmed by real-time viral RNA test …
Convalescent plasma transfusion therapy in severe COVID-19 patients-a safety, efficacy and dose response study: A structured summary of a study protocol of a …
Abstract Objectives General: To assess the safety, efficacy and dose response of
convalescent plasma (CP) transfusion in severe COVID-19 patients Specific: a. To identify …
convalescent plasma (CP) transfusion in severe COVID-19 patients Specific: a. To identify …
Convalescent plasma transfusion for the treatment of COVID‐19: systematic review
K Rajendran, N Krishnasamy… - Journal of medical …, 2020 - Wiley Online Library
The recent emergence of coronavirus disease 2019 (COVID‐19) pandemic has reassessed
the usefulness of historic convalescent plasma transfusion (CPT). This review was …
the usefulness of historic convalescent plasma transfusion (CPT). This review was …
Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low-and middle-income countries
MS Rejeki, N Sarnadi, R Wihastuti, V Fazharyasti… - …, 2021 - thelancet.com
Background We explored the outcome of convalescent plasma (CP) treatment in patients
with moderate and severe coronavirus disease 2019 (COVID-19) and investigated variables …
with moderate and severe coronavirus disease 2019 (COVID-19) and investigated variables …